Rishabh Singh/X
Sep 18, 2025, 07:00
Rishabh Singh on NEJM Letter: FVIII Aurora Mutation Shows Increased Activity and Reduced APC Response
Rishabh Singh, an Heme/Onc fellow at Indiana University, posted on X:
“In a letter to the editor of NEJM, authors describe a naturally occurring FVIII variant, Arg590Ser (designated FVIII Aurora), with substantially increased activity and reduced responsiveness to activated protein C as compared with wild-type FVIII.”
Title: A Naturally Occurring Gain-of-Function Mutation in Factor VIII
Authors: Joshua T. Wischmeyer, Christine H. Baird, Julian Grandvallet Contreras, Alexander Tran, Tzu Phang, Tian Liu, Marilyn J. Manco-Johnson
Read the full version here.
Find similar posts on Hemostasis Today.
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI